Bradley Foster & Sargent’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-500
Closed -$15K – 468
2024
Q3
$15K Hold
500
– – ﹤0.01% 457
2024
Q2
$7.03K Hold
500
– – ﹤0.01% 444
2024
Q1
$9.5K Hold
500
– – ﹤0.01% 439
2023
Q4
$11.1K Hold
500
– – ﹤0.01% 426
2023
Q3
$35.9K Hold
500
– – ﹤0.01% 429
2023
Q2
$35.9K Hold
500
– – ﹤0.01% 429
2023
Q1
$33.7K Sell
500
-100
-17% -$6K ﹤0.01% 426
2022
Q4
$18.6K Buy
600
+100
+20% +$2.97K ﹤0.01% 423
2022
Q3
$14K Hold
500
– – ﹤0.01% 419
2022
Q2
$22K Hold
500
– – ﹤0.01% 433
2022
Q1
$32K Sell
500
-13
-3% -$931 ﹤0.01% 466
2021
Q4
$43K Sell
513
-1,199
-70% -$135K ﹤0.01% 445
2021
Q3
$278K Sell
1,712
-325
-16% -$52.8K 0.01% 369
2021
Q2
$308K Buy
2,037
+43
+2% +$7.25K 0.01% 356
2021
Q1
$346K Buy
1,994
+37
+2% +$7.05K 0.01% 326
2020
Q4
$312K Hold
1,957
– – 0.01% 332
2020
Q3
$312K Buy
+1,957
New +$353K 0.01% 296
2020
Q1
$254K Sell
1,645
-14
-0.8% -$1.41K 0.01% 299
2019
Q4
$128K Sell
1,659
-616
-27% -$53.7K ﹤0.01% 353
2019
Q3
$229K Sell
2,275
-3,663
-62% -$426K 0.01% 324
2019
Q2
$785K Sell
5,938
-663
-10% -$91.1K 0.03% 230
2019
Q1
$999K Sell
6,601
-898
-12% -$140K 0.03% 212
2018
Q4
$1.21M Buy
7,499
+274
+4% +$54.4K 0.05% 188
2018
Q3
$1.86M Buy
7,225
+247
+4% +$61.9K 0.06% 177
2018
Q2
$1.59M Buy
+6,978
New +$1.32M 0.06% 189

Other funds holding CTSO

Bradley Foster & Sargent's CTSO Position: Q4 2024 in Review

Bradley Foster & Sargent sold out of Cytosorbents (CTSO) in Q4 2024, closing a stake of 500 shares — an estimated $15K sold.

Bradley Foster & Sargent first reported a position in CTSO in Q2 2018 and held it in 25 quarters. The position peaked at $1.86M in Q3 2018. 50 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

  • Bradley Foster & Sargent reported no remaining Cytosorbents position as of Q4 2024 after selling out during the quarter.
  • Bradley Foster & Sargent sold 500 Cytosorbents shares in Q4 2024, an estimated $15K.
  • Bradley Foster & Sargent first reported a position in Cytosorbents in Q2 2018 and held it in 25 quarters.
  • Bradley Foster & Sargent's Cytosorbents position peaked at $1.86M in Q3 2018.
  • 50 funds tracked by Wall St. Rank held Cytosorbents as of Q4 2024.

Based on Bradley Foster & Sargent's 13F filing for Q4 2024, filed 3 Feb 2025.